GLAXOSMITHKLINE INTELLECTUAL PROPERTY MAN LIMITED has a total of 23 patent applications. It increased the IP activity by 66.0%. Its first patent ever was published in 2015. It filed its patents most often in EPO (European Patent Office), United States and Australia. Its main competitors in its focus markets pharmaceuticals, biotechnology and organic fine chemistry are P ER FABR MEDIKAMENT, CHARI RAVI V J and QUERCEGEN PHARMA LLC.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 11 | |
#2 | United States | 4 | |
#3 | Australia | 2 | |
#4 | Brazil | 1 | |
#5 | Canada | 1 | |
#6 | Israel | 1 | |
#7 | Republic of Korea | 1 | |
#8 | Mexico | 1 | |
#9 | Taiwan | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Organic fine chemistry | |
#4 | Packaging and shipping | |
#5 | Medical technology | |
#6 | Basic materials chemistry |
# | Name | Total Patents |
---|---|---|
#1 | Perkins Melissa D | 7 |
#2 | Blake-Haskins Angela | 6 |
#3 | Marshall Tristan | 6 |
#4 | Henderson Robert B | 5 |
#5 | Sang Yingxia | 4 |
#6 | O'Berry Kristen | 4 |
#7 | Ren Feng | 4 |
#8 | Xing Weiqiang | 3 |
#9 | Zhan Yang | 3 |
#10 | Zhao Baowei | 3 |
Publication | Filing date | Title |
---|---|---|
EP3796906A1 | Indanes as nrf2 activators | |
EP3573975A1 | Compounds | |
EP3510144A1 | Transduced cell cryoformulation | |
TW201601756A | Antibody formulation |